Symbicort SMART (Symbicort Maintenance And Reliever Therapy)

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

NCT00884689 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

NCT00939341 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

NCT00837967 ·Status: COMPLETED ·Phase: PHASE3

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

NCT00503061 ·Status: COMPLETED

Symbicort SMART Satisfaction From Patient Perspective 2009

NCT00946452 ·Status: COMPLETED

A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

NCT00532922 ·Status: COMPLETED

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

NCT00785733 ·Status: COMPLETED

Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

NCT00524641 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT01647646 ·Status: COMPLETED ·Phase: PHASE4

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

NCT00937066 ·Status: COMPLETED

Local Phase 4 Pan-European SMART Study

NCT00463866 ·Status: COMPLETED ·Phase: PHASE4

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ·Status: COMPLETED ·Phase: PHASE3

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

NCT00252824 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation

NCT01232335 ·Status: COMPLETED

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

NCT00238784 ·Status: COMPLETED ·Phase: PHASE3

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler

NCT00812682 ·Status: COMPLETED

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 ·Status: TERMINATED ·Phase: PHASE3

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00259792 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 ·Status: COMPLETED ·Phase: PHASE4

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

NCT00812357 ·Status: COMPLETED

Effect of Symbicort on GR Localisation in Asthma

NCT00159263 ·Status: COMPLETED ·Phase: NA

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

NCT00628758 ·Status: COMPLETED ·Phase: PHASE3